Galapagos S.A./NV

Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care.
Heart Disease Weekly; 12/6/2009; 1651 words; ...cardiovascular disease than today's Merck," said Dr. Kim...Cardiovascular Care Today's Merck is strengthening and...Cardiome Pharma Corp., Galapagos NV, NicOx, Mochida Pharmaceutical...Group, Brigham and Women's Hospital; Columbia University...

Novartis: - A Detailed And Comprehensive Overview Of Current Financial Position, Company Strategy, Product And Pipeline Analysis.
M2 Presswire; 12/3/2009; 1396 words; ...full review of the company's activities together with...products. The company's financial performance is...comprehensive review of the company's product portfolio and research...Endo Pharmaceuticals - Galapagos NV - Genelabs Technologies...

Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities.
Business Wire; 11/18/2009; 682 words; ...integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies...deCODE Genetics, Inc (Iceland) * Evotec AG (Germany) * Galapagos NV (Belgium) * Incyte Corporation (Formerly Incyte Genomics...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1988 words; ...in September. RSD1235's mechanism of action involves...exclusive license in the U.S. (including Puerto Rico...manufacture and market DepoMed's Metformin GR. The agreement...Today, May 30, 2002.) Galapagos Genomics NV, of Mechelen, Belgium...

Addex Brings In CHF40M For CNS Product Studies.
BIOWORLD Today; 11/3/2009; 1481 words; ...commercialization. "We believe it's the only way to maximize...smoking cessation in the U.S. Its two other drug candidates...schizophrenia and Alzheimer's disease. In other financings...to close at $1.75. o Galapagos NV, of Mechelen, Belgium...